Therapy of 645 children with parapneumonic effusion and empyema-A German nationwide surveillance study

Florian J Segerer1, Karin Seeger1, Anna Maier1

  • 1Department of Pediatrics, University of Würzburg, Würzburg, Germany.

Pediatric Pulmonology
|September 21, 2016
PubMed

Insights

Initial invasive procedures for pediatric parapneumonic effusion or pleural empyema (PPE/PE) did not shorten hospital stays. Treatment effectiveness for pediatric PPE/PE requires further investigation in larger studies.

Area of Science:

  • Pediatric Pulmonology
  • Thoracic Surgery
  • Infectious Diseases

Background:

  • Pediatric parapneumonic effusion or pleural empyema (PPE/PE) is a significant cause of pediatric respiratory illness.
  • Optimal initial management strategies for pediatric PPE/PE remain under investigation to minimize patient morbidity and healthcare costs.

Purpose of the Study:

  • To evaluate the impact of initial management strategies on length of hospital stay (LOS) for pediatric patients diagnosed with PPE/PE.
  • To compare the effectiveness of various invasive procedures in reducing LOS for pediatric PPE/PE.

Main Methods:

  • A nationwide surveillance system (ESPED) was used to collect data on pediatric PPE/PE cases from 2010 to 2013.
  • Patients under 18 requiring drainage or with persistent PPE/PE >7 days were included.
  • Length of hospital stay was compared between patients receiving different initial invasive procedures (pleural puncture, draining catheter, fibrinolytic therapy, surgery) within 3 days of diagnosis.

Main Results:

  • A total of 645 children were included, with a median LOS of 17 days.
  • Initial invasive therapy was administered to 55% of patients; however, LOS did not differ significantly between groups receiving different invasive procedures.
  • Repeated invasive procedures were more common after initial non-invasive treatment or simple pleural puncture compared to more aggressive initial interventions.

Conclusions:

  • Initial management with intrapleural fibrinolytic therapy or surgical procedures did not lead to shorter hospital stays compared to initial pleural puncture alone.
  • Further large-scale prospective studies are necessary to identify specific pediatric patient groups who may benefit from more intensive initial invasive treatments for PPE/PE.
Abstract

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
965
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
999
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.3K
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
2.3K